VC firms
Vanguard Accelerator
Edit

Vanguard Accelerator

Trusted
https://www.biopole.ch/
Last activity: 09.10.2026
Active
Biopôle is a large life sciences campus in Lausanne, Switzerland. Find out how we help life sciences experts achieve their goals and change the world.
Mentions
77

Mentions in press and media 77

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Aug 19, 2026Bewe awarded Biopôle Pre-Clinical Top-Up Indeed, Bewe previously participated in Biopôle’s Investment Readiness Programme and Start-Up Fund, which not only financed R&D and infrastructure but also helped the start-up’s team hone their business plan and investment strategy. Ha...
Jul 24, 2026MoleSense and Impli selcted for SPRIND Challenge on Continuous Hormone Monitoring Hormones control nearly every process in the human body – from metabolism and immune function to cognition and reproduction. Yet how we measure them is static. Women are particularly affected. Their hormonal systems show the greatest varia...
Jun 25, 2026MoleSense enters Biopôle’s Investment Programme A boost at a critical moment Founded in 2025 by EPFL alumni Gian Luca Barbruni and Ata Golparvar, MoleSense is advancing women’s healthcare through molecular wearable technology. Its core innovation is a patch-like medical device that cont...
May 13, 2026Nalgoova Therapeutics enters Biopôle’s Vanguard Accelerator For Nalgoova – a Swiss start-up seeking to transform migraine care from generalized symptom management to precise, patient-specific treatment – the programme’s execution focus was a key draw. ‘What we value most is the emphasis on rapid, i...
Apr 2, 2026BIND 2026 Crowns Four Swiss Health Gems BioAlps proudly celebrated the most promising life sciences innovations emerging from Western Switzerland at the BIND – BioInnovation Day 2026, held at CHUV and attended by 340 participants from academia, healthcare, industry, investment a...
Mar 2, 2026CHD enters Biopôle Vanguard Accelerator Founded in 2026 and headquartered at Biopôle’s campus in Lausanne, CHD is a medtech and e-health service operator advancing maternal–fetal health through an innovative healthcare-certified e-textile belt designed for real-life monitoring c...
Feb 4, 2026MoleSense wins over Vanguard Accelerator Founded in 2025 by EPFL alumni Gian Luca Barbruni and Ata Golparvar, MoleSense is advancing women’s healthcare through molecular wearable technology. Moving beyond tracking vital signs, its core innovation is a new class of medical devices...
Nov 6, 2025Switchkine leads first Biopôle Investment Program recipient cohort The Biopôle Investment Programme is a comprehensive 24-month scheme for start-ups based on the Biopôle campus. The programme offers more than financial support, seeking to help start-ups build the foundations of long-term success by provid...
Oct 31, 2025More than 20 Swiss biotech companies to exhibit at Bio Europe Bio-Europe, the leading partnering conference for the global biotechnology industry, is held annually to connect biotech, pharma, investors, and service providers through one-to-one meetings, presentations, and panels. It serves as a leadi...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Vanguard Accelerator

What has the press written about Vanguard Accelerator?

Parsers VC has collected 77 articles mentioning Vanguard Accelerator, among them “Bewe awarded Biopôle Pre-Clinical Top-Up” (Aug 19, 2026) and “MoleSense and Impli selcted for SPRIND Challenge on Continuous Hormone Monitoring” (Jul 24, 2026).

Is Vanguard Accelerator still active?

Yes, Vanguard Accelerator is active; its latest activity on Parsers VC dates from Oct 9, 2026.